{
    "url_original": "https://www.wsj.com/articles/pfizer-sales-soar-on-covid-19-vaccine-sales-11651581988?mod=business_lead_pos3",
    "url": "pfizer-sales-soar-on-covid-19-vaccine-sales-11651581988",
    "title": "Pfizer Sales Soar on Covid-19 Vaccine Sales",
    "sub_head": "Drug giant logs 77% revenue increase helped by Covid vaccine, antiviral medications",
    "category_1": "Business",
    "category_2": "Earnings",
    "time": "2022-05-03 08:58:00",
    "body": "Pfizer Inc.â€™s  first-quarter sales soared 77%, helped by higher revenue from its Covid-19 vaccine and antiviral medication.<br />The New York-based drug company logged $25.7 billion in sales in the first-quarter, driven by sales of its vaccine, Comirnaty, and Paxlovid, a pill aimed at reducing severe outcomes from the virus."
}